Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Solesence (SLSN) Current Deferred Revenue (2018 - 2025)

Historic Current Deferred Revenue for Solesence (SLSN) over the last 9 years, with Q3 2025 value amounting to $1.2 million.

  • Solesence's Current Deferred Revenue fell 8078.03% to $1.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.2 million, marking a year-over-year decrease of 8078.03%. This contributed to the annual value of $5.6 million for FY2024, which is 13676.16% up from last year.
  • Per Solesence's latest filing, its Current Deferred Revenue stood at $1.2 million for Q3 2025, which was down 8078.03% from $2.2 million recorded in Q2 2025.
  • Solesence's Current Deferred Revenue's 5-year high stood at $6.2 million during Q3 2024, with a 5-year trough of $388000.0 in Q3 2021.
  • For the 5-year period, Solesence's Current Deferred Revenue averaged around $2.2 million, with its median value being $2.1 million (2023).
  • Its Current Deferred Revenue has fluctuated over the past 5 years, first soared by 22737.5% in 2023, then tumbled by 8078.03% in 2025.
  • Solesence's Current Deferred Revenue (Quarter) stood at $783000.0 in 2021, then surged by 176.76% to $2.2 million in 2022, then increased by 8.58% to $2.4 million in 2023, then surged by 136.76% to $5.6 million in 2024, then crashed by 78.51% to $1.2 million in 2025.
  • Its Current Deferred Revenue was $1.2 million in Q3 2025, compared to $2.2 million in Q2 2025 and $4.6 million in Q1 2025.